Hofseth BioCare ASA Celebrates Award-Winning Innovation
Recently, Hofseth BioCare ASA has marked a significant achievement as its innovative product, ProGo®, was honored with the Ingredient of the Year for Healthy Aging at a prestigious awards ceremony. This recognition highlights ProGo®'s uniqueness, particularly its ability to activate GLP-1 and GIP receptors, which offers promising health benefits.
What Makes ProGo® Stand Out?
The judges noted that ProGo® surpassed the competition with its impressive sustainability credentials, including its Upcycled Certified status. More notably, clinical studies have demonstrated ProGo®’s effectiveness in promoting weight loss, a benefit that resonates well with health-conscious consumers.
Health Benefits of ProGo® Bioactive Peptides
ProGo® Bioactive Peptides play a crucial role in optimizing glucose and fat metabolism. They enhance energy levels while positively influencing weight management. This innovative approach not only supports individual health but also extends the healthspan across different age groups, encouraging a more active lifestyle.
Applications in Consumer Health and Nutrition
With its unique formulation, ProGo® is garnering significant attention in both consumer health and medical nutrition sectors. Its multifunctional applications reflect current health trends focusing on preventative care and overall wellness.
Company Profile: Hofseth BioCare ASA
Hofseth BioCare ASA is a Norwegian company dedicated to enhancing health through sustainability and optimal resource utilization. By converting by-products of the salmon industry into nutritional ingredients, Hofseth leads the way in eco-conscious practices. Their flagship products include ProGo®, a combination of bioactive peptides and collagen, OmeGo®, a whole salmon oil, and CalGo® / NT-II™ salmon bone powder designed for bone and joint health.
Scientific Innovation at the Forefront
Hofseth BioCare champions scientific research, resulting in robust academic partnerships that validate the health claims of their products. ProGo® has been shown to improve iron metabolism, thereby boosting energy and vitality. Moreover, it activates the GLP-1 receptor linked to fat reduction in overweight adults, showcasing its dual benefit in weight management and overall health enhancement.
Additional Product Benefits
The benefits of Hofseth’s offerings extend beyond individual health. OmeGo® provides significant immune system support, showcasing recovery from viral infections and enhanced respiratory health. Meanwhile, CalGo® proves beneficial for maintaining bone density and joint health, which is especially important for older demographics and active individuals.
Future Prospects and Research Initiatives
Hofseth BioCare is not just resting on its laurels; they are actively pursuing new research avenues, which have led to the establishment of a biotech-focused subsidiary, HBC Immunology. This offshoot focuses on developing therapeutic applications, with projects currently addressing prostate and ovarian cancer, as well as advancements in asthma treatment.
Contact Details for Inquiries
For more information regarding Hofseth BioCare's offerings or for media inquiries, please reach out to:
James Berger, Chief Commercial Officer of Hofseth BioCare ASA
Phone: +41 799501034
E-mail: jb@hofsethbiocare.com
Frequently Asked Questions
What is ProGo® and what are its main benefits?
ProGo® is a bioactive peptide product that aids in weight management and improves energy levels by optimizing glucose and fat metabolism.
How does Hofseth BioCare ensure sustainability?
The company upcycles by-products from the salmon industry, converting waste into valuable ingredients that promote health while maintaining environmental responsibility.
What other products does Hofseth BioCare offer?
Alongside ProGo®, they offer OmeGo®, a whole salmon oil, and CalGo® / NT-II™, a salmon bone powder designed to support bone and joint health.
What kind of research does Hofseth BioCare conduct?
The company is focused on scientific research that validates the health benefits of its products and explores new therapeutic uses, including cancer and asthma treatments.
Who can I contact for more information about Hofseth BioCare?
You can contact James Berger at +41 799501034 or via email at jb@hofsethbiocare.com for inquiries.
